大禹金融(01073.HK)擬收購按揭貸款
格隆匯3月24日丨大禹金融(01073.HK)發佈公吿,2022年3月24日,買方(公司的全資附屬公司)(作為買方及受讓人)與賣方A及賣方B(作為賣方及轉讓人)分別訂立轉讓契據,據此:1)賣方A已同意以現金代價約1730萬港元向買方出售、出讓及轉讓其有關貸款A的所有權利、所有權及權益,以及有關貸款A的所有抵押品及任何類型擔保;及2)賣方B已同意以現金代價約2630萬港元向買方出售、出讓及轉讓其有關貸款B的所有權利、所有權及權益,以及有關貸款B的所有抵押品及任何類型擔保。
收購事項實質上將導致買方向借款人提供本金總額約4270萬港元的貸款,每筆貸款的利率及到期日列於各貸款協議,並由各抵押文件所規定的抵押品作抵押。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.